NCT03786744View on ClinicalTrials.gov

Allogenic Cord Blood Transfusion in Patients With Autism

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 12, 2018

Primary Completion Date

October 12, 2019

Study Completion Date

December 12, 2019

Conditions
Autism Spectrum DisorderAutism
Interventions
BIOLOGICAL

ASD CB-MNC injection.

CB-MNC injection from different donors. One dose consist 20-50 mil MNC/kg.The protocol include 3 injection at monthly intervals.

OTHER

Standard therapy.

The standard therapy can include drugs, special psychology training etc.

Trial Locations (1)

443095

Medical Centre Dinasty, Samara

All Listed Sponsors
lead

"State-Financed Health Facility Samara Regional Medical Center Dinasty"

OTHER

NCT03786744 - Allogenic Cord Blood Transfusion in Patients With Autism | Biotech Hunter | Biotech Hunter